Xanit bolts on Croasa

The deal was funded via a €610,000 capital commitment from N+1 through its Dinamia fund, which is listed on the Madrid Stock Exchange.

N+1 participated in the buyout of Xanit in 2007, acquiring a 62.5% stake in exchange for a €42m contribution. The remaining stake in the firm was retained by Partners Group, Lombard Odier Darier Hentsch & Cie and the management team.

In 2011, N+1 committed a further €3.2m in growth capital to the firm to fund the construction of an outpatient clinic and the expansion of the children's accident and emergency department.

Company
Croasa comprises the Andalusian Radio-Oncology Centre and Integral Medical Oncology Centre. The previous owner was an Andalusian group dedicated to cancer treatments. Croasa was opened in 1989 and has agreements with major national and international insurance companies to provide radiotherapy services.

People
David Santos of N+1 led the 2011 growth capital deal.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Southern Europe
• Healthcare
• Portfolio management
• Spain